The current understanding of motor neuron disease

Current Anaesthesia and Critical Care

Volumn 20, Issue 5-6, 2009, Pages 236-239

  Burvill, Emma ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Dynein; Motor neuron disease; Protein aggregation; Superoxide dismutase

Indexed keywords

CHAPERONE; COPPER ZINC SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN 70; MUTANT PROTEIN; RILUZOLE; SINGLE STRANDED RNA; SMALL INTERFERING RNA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CELL STRESS; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; GENE MUTATION; GENE SILENCING; GENETIC RISK; HUMAN; HUNTINGTON CHOREA; MOTONEURON; MOTOR NEURON DISEASE; MUSCLE ATROPHY; MUTATIONAL ANALYSIS; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; NONVIRAL GENE THERAPY; OXIDATIVE STRESS; PARALYSIS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEFECT; PROTEIN FOLDING; PROTEIN PROCESSING; RNA INTERFERENCE;

EID: 69649095389     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2009.07.009     Document Type: Article

References (15)

1. MND Association, .
2. Shaw P.J. Science, medicine and the future: motor neuron disease. BMJ 318 (1999) 1118-1121
3. Sherman M.Y., and Goldberg A.L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29 (2001) 15-32
4. Furukawa, Kaneko, Yamanaka, O'Halloran, and Nukina. Complete loss of post-translational modification triggers fibrillar aggregation of SOD1 in fALS. J Biol Chem 283 35 (2008) 24167-24176
5. Urushitani M., Abou Ezzi S., Matsuo A., Tooyama I., and Julien J.P. The ER-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J 22 7 (2008) 2476-2487
6. Oh Y.K., Shin K.S., Yuan J.Y., and Kang S.J. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells. J Neurochem 4 (2008) 993-1005
7. Ström, Gal, Shi, Kasarskis, Hayward, and Zhu. Retrograde axonal transport and motor neuron disease. J Neurochem 106 (2008) 405-505
8. Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 4 9 (2008) e1000193
9. Lai C., Lin X., Chandran J., Shim H., Yang W.J., and Cai H.B. The G59S mutation in p150glued causes dysfunction of dynactin in mice. J Neurosci 27 51 (2007) 13982-13990
10. Kimura N., Imamura O., Ono F., and Terao K. Aging attenuates dynactin-dynein interaction: down-regulation of dynein causes accumulation of endogenous tau and amyloid precursor protein in human neuroblastoma cells. J Neurosci Res 85 (2007) 2909-2916
11. Sayre L.M., Perry G., and Smith M.A. Oxidative stress and neurotoxicity. Chem Res Toxicol 1 (2008) 172-188
12. Wang H.Y., Ghosh A., Baigude H., Yang C.S., Qiu L.H., Xia X.G., et al. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression. J Biol Chem 283 23 (2008) 15845-15852
13. Kieran D., Kalmar B., Dick J.R.T., Riddoch-Contreras J., Burnstock G., and Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 10 (2004) 402-405
14. Yamashita H., Kawamata J., Okawa K., Kanki R., Nakamizo T., Hatayama T., et al. Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn Superoxide dismutase: clues to a possible strategy for treating ALS. J Neurochem 102 (2007) 1497-1505
15. Levy J.R., Sumner C.J., Caviston J.P., Tokito M.K., Ranganathan S., Ligon L.A., et al. A motor neuron disease-associated mutation in p150glued perturbs dynactin function and induces protein aggregation. J Cell Biol 172 (2006) 733-745